← Leaderboards
Todd W Miller
Medical College Of Wisconsin
$9,811,642
Attributed
$9,811,642
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,811,642 · 8
By mechanism
R01$8,644,527 · 4
R00$705,943 · 1
K99$281,718 · 1
F32$100,924 · 1
F31$78,530 · 1
Top collaborators
No co-investigators on record.
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- Kathryn E Flynn$4,334,105
- Joan Marie Neuner$5,454,746
- Ann B. Nattinger$10,426,229
- Liliana E. Pezzin$4,020,428
- Santanu Bose$4,095,641
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMalignant Breast NeoplasmCancer CellMalignant NeoplasmsBreast Cancer CellRecurrenceResistanceResponseEstrogensClinical TrialsMortalityPreventGrowthCellsSignal TransductionDisease ProgressionCell LineMorbidity - Disease RateErbb2 GeneAromatase InhibitorsEstrogen AntagonistsInsightDrug ResistanceEstrogen Receptor Alpha
Grant awards (39)
A precision medicine basis for estrogen therapy for advanced breast cancer$379,345
R01 · FY2025 · CA · contact PI
Therapeutically leveraging metabolic vulnerabilities in breast cancer$365,369
R01 · FY2025 · CA · contact PI
Uncovering the basis and implications of lineage plasticity in breast cancer$356,850
R01 · FY2025 · CA · contact PI
A precision medicine basis for estrogen therapy for advanced breast cancer$360,341
R01 · FY2024 · CA · contact PI
Uncovering the basis and implications of lineage plasticity in breast cancer$342,550
R01 · FY2024 · CA · contact PI
Therapeutically leveraging metabolic vulnerabilities in breast cancer$283,575
R01 · FY2024 · CA · contact PI
Therapeutically leveraging metabolic vulnerabilities in breast cancer$176,918
R01 · FY2024 · CA · contact PI
Therapeutically leveraging metabolic vulnerabilities in breast cancer$516,202
R01 · FY2023 · CA · contact PI
A precision medicine basis for estrogen therapy for advanced breast cancer$242,634
R01 · FY2023 · CA · contact PI
Uncovering the basis and implications of lineage plasticity in breast cancer$217,804
R01 · FY2023 · CA · contact PI
Uncovering the basis and implications of lineage plasticity in breast cancer$156,594
R01 · FY2023 · CA · contact PI
A precision medicine basis for estrogen therapy for advanced breast cancer$142,699
R01 · FY2023 · CA · contact PI
Therapeutically leveraging metabolic vulnerabilities in breast cancer$34,304
R01 · FY2023 · CA · contact PI
Therapeutically leveraging metabolic vulnerabilities in breast cancer$1
R01 · FY2023 · CA · contact PI
A precision medicine basis for estrogen therapy for advanced breast cancer$398,676
R01 · FY2022 · CA · contact PI
Therapeutically leveraging metabolic vulnerabilities in breast cancer$383,986
R01 · FY2022 · CA · contact PI
Uncovering the basis and implications of lineage plasticity in breast cancer$379,548
R01 · FY2022 · CA · contact PI
A precision medicine basis for estrogen therapy for advanced breast cancer$370,575
R01 · FY2021 · CA · contact PI
Timing is everything: applications in precision oncology for ER+ breast cancer$370,575
R01 · FY2021 · CA · contact PI
Timing is everything: applications in precision oncology for ER+ breast cancer$74,539
R01 · FY2021 · CA · contact PI
Timing is everything: applications in precision oncology for ER+ breast cancer$445,114
R01 · FY2020 · CA · contact PI
A precision medicine basis for estrogen therapy for advanced breast cancer$370,575
R01 · FY2020 · CA · contact PI
A precision medicine basis for estrogen therapy for advanced breast cancer$359,457
R01 · FY2019 · CA · contact PI
Timing is everything: applications in precision oncology for ER+ breast cancer$359,457
R01 · FY2019 · CA · contact PI
Timing is everything: applications in precision oncology for ER+ breast cancer$74,539
R01 · FY2019 · CA · contact PI
Timing is everything: applications in precision oncology for ER+ breast cancer$370,575
R01 · FY2018 · CA · contact PI
A precision medicine basis for estrogen therapy for advanced breast cancer$370,575
R01 · FY2018 · CA · contact PI
A precision medicine basis for estrogen therapy for advanced breast cancer$370,575
R01 · FY2017 · CA · contact PI
Timing is everything: applications in precision oncology for ER+ breast cancer$370,575
R01 · FY2017 · CA · contact PI
The effects of PTEN on tyrosine kinase signaling in Breast Cancer$228,390
R00 · FY2014 · CA · contact PI
The effects of PTEN on tyrosine kinase signaling in Breast Cancer$228,553
R00 · FY2013 · CA · contact PI
The effects of PTEN on tyrosine kinase signaling in Breast Cancer$249,000
R00 · FY2012 · CA · contact PI
The effects of PTEN on tyrosine kinase signaling in breast cancer$142,462
K99 · FY2011 · CA · contact PI
The effects of PTEN on tyrosine kinase signaling in breast cancer$139,256
K99 · FY2010 · CA · contact PI
Modulation of aromatase: implications for breast cancer$51,278
F32 · FY2008 · CA · contact PI
Modulation of aromatase: implications for breast cancer$49,646
F32 · FY2007 · CA · contact PI
Intrabody Therapy for Huntington's Disease$25,186
F31 · FY2004 · NS
Intrabody Therapy for Huntington's Disease$27,578
F31 · FY2003 · NS
Intrabody Therapy for Huntington's Disease$25,766
F31 · FY2002 · NS